Page last updated: 2024-11-12

alendronate sodium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alendronate sodium trihydrate : A hydride that is the trihydrate of alendronate sodium [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16760285
CHEMBL ID675
SCHEMBL ID328770
MeSH IDM0329075
PubMed CID23681107
CHEMBL ID2367465
CHEBI ID2566
MeSH IDM0329075

Synonyms (156)

Synonym
nsc-722597
indrol
(4-amino-1-hydroxybutylidene)bisphosphonic acid monosodium salt
osteovan
phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt
mk 217
neobon
monosodium alendronate
alend
g-704650
alendronate sodium
mk-217
onclast
binosto
gth-42v
alendronic acid sodium salt
teiroc
gth-42
ahbutbp
steovess
gth-42w
fosamax
gth-42j
mk-0217
ahbubp
fosamac
bonalon
l-670452
avalent
almerol
ex-101
mer-103
adrovance
nsc-758931
vantavo
CHEMBL675
A805927
alendronate monosodium
129318-43-0
alendronic acid monosodium salt
(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid monosodium salt
monosodium (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate
unii-4988k7x26p
4988k7x26p ,
alendronate sodium anhydrous
AKOS015895071
phosphonic acid, p,p'-(4-amino-1-hydroxybutylidene)bis-, sodium salt (1:1)
4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid monosodium salt
sodium alendronate anhydrous
CCG-220631
sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate
SCHEMBL328770
CAKRAHQRJGUPIG-UHFFFAOYSA-M
alendronic acid, sodium aldendronate
KS-1028
p,p'-(4-amino-1-hydroxybutylidene)bis-phosphonic acid monosodium salt
HMS3604I12
J-005667
mfcd01861681
HMS3713P04
bdbm50247920
DTXSID70904501 ,
sodium hydrogen-4-amino-1-hydroxy-1-phosphonobutylphosphonate
onclast; osteovan; sodium alendronate
BCP28464
mk 217;mk-217;mk217;sodium alendronate
Q27259256
sodium;(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate
CS-0029477
HY-108685
EN300-7373370
121268-17-5
alendronate sodium trihydrate, >=97% (nmr), powder
g-704,650
monosodium (4-amino-1-hydroxybutylidene)bisphosphonate trihydrate
dronal
aminohydroxybutylidene biphosphonate monosodium salt trihydrate
sodium trihydrogen (4-amino-1-hydroxybutylidene)diphosphonate, trihydrate
alendronate sodium [usan]
elandor
sodium alendronate hydrate
adronat
fosalan
phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt, trihydrate
alendronate sodium hydrate
alendros
binosto (tn)
alendronate sodium (usp)
alendronate sodium hydrate (jp17)
D00939
fosamax (tn)
alendronate sodium trihydrate
sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate trihydrate
CHEBI:2566 ,
alendronic acid monosodium salt trihydrate
sodium alendronate trihydrate
alendronate (as sodium)
sodium alendronate
A804705
alendronate monosodium trihydrate
dtxcid5027778
dtxsid7047801 ,
cas-121268-17-5
tox21_111553
AKOS015960820
AKOS016010492
nsc 758931
2uy4m2u3ra ,
nsc 722597
unii-2uy4m2u3ra
alendronate sodium [usan:usp]
FT-0601586
AB09896
alendronate sodium [who-dd]
alendronate sodium [usp-rs]
alendronate sodium hydrate [jan]
alendronate sodium [usp monograph]
alendronic acid (as alendronate sodium)
sodium alendronate trihydrate [ep monograph]
alendronate sodium [orange book]
fosamax plus d component alendronate sodium
alendronate sodium trihydrate [ema epar]
alendronic acid monosodium salt trihydrate [mi]
alendronate sodium component of fosamax plus d
CHEMBL2367465
NCGC00263967-02
tox21_111553_1
4-amino-1-hydroxy-1-phosphonobutyl phosphonic acid monosodium trihydrate
sodium trihydrogen 4-amino-1-hydroxybutylidenediphosphonate trihydrate
DCSBSVSZJRSITC-UHFFFAOYSA-M
alendronate monosodium salt trihydrate
Q-200606
sodium trihydrate hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate
DS-2820
alendronate sodium salt trihydrate
mfcd01748233
AC-8070
alendronate sodium, united states pharmacopeia (usp) reference standard
g-704650 adronat
C90614
sodium alendronate trihydrate, european pharmacopoeia (ep) reference standard
alendronate sodium, pharmaceutical secondary standard; certified reference material
sodium;(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate;trihydrate
BCP22746
SY070842
Q27105722
sodium;(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid
(4-amino-1-hydroxybutylidene) bisphosphonic acid monosodium salt trihydrate.
alendronatemonosodiumtrihydrate
BA164144
sodium alendronate for system suitability
alendronate sodium tablet
dtxcid501333649
alendronate sodium (usp-rs)
alendronate sodium (usp monograph)
sodium alendronate trihydrate (ep monograph)

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
bone density conservation agentAn agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis.
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitorAn EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that interferes with the action of dimethylallyltranstransferase (EC 2.5.1.1).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organic sodium salt
hydrateAn addition compound that contains water in weak chemical combination with another compound.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency2.68320.000214.376460.0339AID720691
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-binding cassette sub-family C member 3Homo sapiens (human)IC50 (µMol)133.00000.63154.45319.3000AID1473740
Multidrug resistance-associated protein 4Homo sapiens (human)IC50 (µMol)133.00000.20005.677410.0000AID1473741
Bile salt export pumpHomo sapiens (human)IC50 (µMol)133.00000.11007.190310.0000AID1473738
Interstitial collagenaseHomo sapiens (human)IC50 (µMol)100.00000.00020.850210.0000AID1852267
72 kDa type IV collagenaseHomo sapiens (human)IC50 (µMol)100.00000.00001.284810.0000AID1852268
Stromelysin-1Homo sapiens (human)IC50 (µMol)100.00000.00001.148410.0000AID1852269
Farnesyl pyrophosphate synthaseHomo sapiens (human)IC50 (µMol)0.46000.00020.71099.3600AID1569244
Canalicular multispecific organic anion transporter 1Homo sapiens (human)IC50 (µMol)133.00002.41006.343310.0000AID1473739
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (96)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
bile acid and bile salt transportATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transportATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
leukotriene transportATP-binding cassette sub-family C member 3Homo sapiens (human)
monoatomic anion transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transport across blood-brain barrierATP-binding cassette sub-family C member 3Homo sapiens (human)
prostaglandin secretionMultidrug resistance-associated protein 4Homo sapiens (human)
cilium assemblyMultidrug resistance-associated protein 4Homo sapiens (human)
platelet degranulationMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
bile acid and bile salt transportMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transportMultidrug resistance-associated protein 4Homo sapiens (human)
urate transportMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
cAMP transportMultidrug resistance-associated protein 4Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 4Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 4Homo sapiens (human)
guanine nucleotide transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
proteolysisInterstitial collagenaseHomo sapiens (human)
protein metabolic processInterstitial collagenaseHomo sapiens (human)
extracellular matrix disassemblyInterstitial collagenaseHomo sapiens (human)
collagen catabolic processInterstitial collagenaseHomo sapiens (human)
positive regulation of protein-containing complex assemblyInterstitial collagenaseHomo sapiens (human)
cellular response to UV-AInterstitial collagenaseHomo sapiens (human)
extracellular matrix organizationInterstitial collagenaseHomo sapiens (human)
angiogenesis72 kDa type IV collagenaseHomo sapiens (human)
ovarian follicle development72 kDa type IV collagenaseHomo sapiens (human)
ovulation from ovarian follicle72 kDa type IV collagenaseHomo sapiens (human)
luteinization72 kDa type IV collagenaseHomo sapiens (human)
blood vessel maturation72 kDa type IV collagenaseHomo sapiens (human)
intramembranous ossification72 kDa type IV collagenaseHomo sapiens (human)
proteolysis72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of cell adhesion72 kDa type IV collagenaseHomo sapiens (human)
heart development72 kDa type IV collagenaseHomo sapiens (human)
embryo implantation72 kDa type IV collagenaseHomo sapiens (human)
parturition72 kDa type IV collagenaseHomo sapiens (human)
response to xenobiotic stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to mechanical stimulus72 kDa type IV collagenaseHomo sapiens (human)
peripheral nervous system axon regeneration72 kDa type IV collagenaseHomo sapiens (human)
response to activity72 kDa type IV collagenaseHomo sapiens (human)
protein metabolic process72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix disassembly72 kDa type IV collagenaseHomo sapiens (human)
protein catabolic process72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of cell migration72 kDa type IV collagenaseHomo sapiens (human)
collagen catabolic process72 kDa type IV collagenaseHomo sapiens (human)
response to retinoic acid72 kDa type IV collagenaseHomo sapiens (human)
cellular response to reactive oxygen species72 kDa type IV collagenaseHomo sapiens (human)
response to nicotine72 kDa type IV collagenaseHomo sapiens (human)
endodermal cell differentiation72 kDa type IV collagenaseHomo sapiens (human)
response to hydrogen peroxide72 kDa type IV collagenaseHomo sapiens (human)
response to estrogen72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of vasoconstriction72 kDa type IV collagenaseHomo sapiens (human)
ephrin receptor signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
macrophage chemotaxis72 kDa type IV collagenaseHomo sapiens (human)
response to electrical stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to hyperoxia72 kDa type IV collagenaseHomo sapiens (human)
face morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
bone trabecula formation72 kDa type IV collagenaseHomo sapiens (human)
prostate gland epithelium morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
cellular response to amino acid stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to interleukin-172 kDa type IV collagenaseHomo sapiens (human)
cellular response to estradiol stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to UV-A72 kDa type IV collagenaseHomo sapiens (human)
cellular response to fluid shear stress72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
response to amyloid-beta72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix organization72 kDa type IV collagenaseHomo sapiens (human)
response to hypoxia72 kDa type IV collagenaseHomo sapiens (human)
tissue remodeling72 kDa type IV collagenaseHomo sapiens (human)
proteolysisStromelysin-1Homo sapiens (human)
extracellular matrix disassemblyStromelysin-1Homo sapiens (human)
protein catabolic processStromelysin-1Homo sapiens (human)
regulation of cell migrationStromelysin-1Homo sapiens (human)
collagen catabolic processStromelysin-1Homo sapiens (human)
positive regulation of protein-containing complex assemblyStromelysin-1Homo sapiens (human)
cellular response to reactive oxygen speciesStromelysin-1Homo sapiens (human)
innate immune responseStromelysin-1Homo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionStromelysin-1Homo sapiens (human)
cellular response to lipopolysaccharideStromelysin-1Homo sapiens (human)
cellular response to amino acid stimulusStromelysin-1Homo sapiens (human)
cellular response to UV-AStromelysin-1Homo sapiens (human)
cellular response to nitric oxideStromelysin-1Homo sapiens (human)
regulation of neuroinflammatory responseStromelysin-1Homo sapiens (human)
response to amyloid-betaStromelysin-1Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processStromelysin-1Homo sapiens (human)
extracellular matrix organizationStromelysin-1Homo sapiens (human)
cholesterol biosynthetic processFarnesyl pyrophosphate synthaseHomo sapiens (human)
geranyl diphosphate biosynthetic processFarnesyl pyrophosphate synthaseHomo sapiens (human)
farnesyl diphosphate biosynthetic processFarnesyl pyrophosphate synthaseHomo sapiens (human)
xenobiotic metabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
negative regulation of gene expressionCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bile acid and bile salt transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
heme catabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic export from cellCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transepithelial transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
leukotriene transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
monoatomic anion transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (35)

Processvia Protein(s)Taxonomy
ATP bindingATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type bile acid transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATP hydrolysis activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
icosanoid transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
guanine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ATP bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
urate transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
purine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type bile acid transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
15-hydroxyprostaglandin dehydrogenase (NAD+) activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
endopeptidase activityInterstitial collagenaseHomo sapiens (human)
metalloendopeptidase activityInterstitial collagenaseHomo sapiens (human)
serine-type endopeptidase activityInterstitial collagenaseHomo sapiens (human)
peptidase activityInterstitial collagenaseHomo sapiens (human)
zinc ion bindingInterstitial collagenaseHomo sapiens (human)
fibronectin binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
metalloendopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
serine-type endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
protein binding72 kDa type IV collagenaseHomo sapiens (human)
metallopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
zinc ion binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activityStromelysin-1Homo sapiens (human)
metalloendopeptidase activityStromelysin-1Homo sapiens (human)
serine-type endopeptidase activityStromelysin-1Homo sapiens (human)
protein bindingStromelysin-1Homo sapiens (human)
peptidase activityStromelysin-1Homo sapiens (human)
metallopeptidase activityStromelysin-1Homo sapiens (human)
zinc ion bindingStromelysin-1Homo sapiens (human)
RNA bindingFarnesyl pyrophosphate synthaseHomo sapiens (human)
protein bindingFarnesyl pyrophosphate synthaseHomo sapiens (human)
metal ion bindingFarnesyl pyrophosphate synthaseHomo sapiens (human)
dimethylallyltranstransferase activityFarnesyl pyrophosphate synthaseHomo sapiens (human)
geranyltranstransferase activityFarnesyl pyrophosphate synthaseHomo sapiens (human)
protein bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
organic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type xenobiotic transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP hydrolysis activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basal plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basolateral plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
nucleolusMultidrug resistance-associated protein 4Homo sapiens (human)
Golgi apparatusMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
platelet dense granule membraneMultidrug resistance-associated protein 4Homo sapiens (human)
external side of apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
extracellular regionInterstitial collagenaseHomo sapiens (human)
extracellular matrixInterstitial collagenaseHomo sapiens (human)
extracellular spaceInterstitial collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular region72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
nucleus72 kDa type IV collagenaseHomo sapiens (human)
mitochondrion72 kDa type IV collagenaseHomo sapiens (human)
plasma membrane72 kDa type IV collagenaseHomo sapiens (human)
sarcomere72 kDa type IV collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
extracellular regionStromelysin-1Homo sapiens (human)
nucleusStromelysin-1Homo sapiens (human)
mitochondrionStromelysin-1Homo sapiens (human)
cytosolStromelysin-1Homo sapiens (human)
extracellular matrixStromelysin-1Homo sapiens (human)
extracellular spaceStromelysin-1Homo sapiens (human)
nucleoplasmFarnesyl pyrophosphate synthaseHomo sapiens (human)
cytosolFarnesyl pyrophosphate synthaseHomo sapiens (human)
cytoplasmFarnesyl pyrophosphate synthaseHomo sapiens (human)
plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
cell surfaceCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
intercellular canaliculusCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (101)

Assay IDTitleYearJournalArticle
AID351140Cytotoxicity against human MADS cells at 100 nM2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
A one step/one pot synthesis of N,N-bis(phosphonomethyl)amino acids and their effects on adipogenic and osteogenic differentiation of human mesenchymal stem cells.
AID1852279Inhibition of Bacillus cereus collagenase infected in NHDF cells assessed as suppression of gelatin lysis at 200 uM incubated for 1 to 6 hrs by coomassie brilliant blue staining based zymography analysis2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1852269Inhibition of human recombinant MMP-32022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1569222Antiosteoporotic activity in ddY mouse model of OVX-induced osteoporosis assessed as increase in ratio of bone volume/trabecular volume in femur bone at 10 mg/kg, po administered once daily via gavage for 4 weeks by microcomputed tomographic analysis
AID216549Effective concentration range of compound was determined in stimulating Vgamma9 / Vdelta2 T cell2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism.
AID1852286Inhibition of Bacillus cereus collagenase infected in NHDF cells assessed as fibrillar extra cellular matrix at > 100 uM incubated for 1 to 6 hrs by coomassie brilliant blue staining based SDS-PAGE analysis2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1250253Metal chelating activity in human PE/CA-PJ15 cells assessed as change in cytosolic Ca2+ concentration at 60 uM after 50 secs using Ca2+ containing medium by FURA-2 AM probe-based spectrophotofluorometric analysis2015European journal of medicinal chemistry, Sep-18, Volume: 102Synthesis of new indole-based bisphosphonates and evaluation of their chelating ability in PE/CA-PJ15 cells.
AID1569250Toxicity in ddY mouse model of OVX-induced osteoporosis assessed as increase in body weight at 10 mg/kg, po administered once daily via gavage for 4 weeks measured 5 weeks post OVX-challenge
AID1250255Metal chelating activity in human PE/CA-PJ15 cells assessed as change in cytosolic Ca2+ concentration at 10 to 30 uM after 50 secs using Ca2+ free medium by FURA-2 AM probe-based spectrophotofluorometric analysis2015European journal of medicinal chemistry, Sep-18, Volume: 102Synthesis of new indole-based bisphosphonates and evaluation of their chelating ability in PE/CA-PJ15 cells.
AID1852265Inhibition of Bacillus cereus ATCC 14579 collagenase unit of ColA at 100 uM relative to control2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1894363Induction of osteoblast differentiation in transgenic osx mCherry Zebrafish embryo assessed as increase in Col10a1a mRNA expression in fin at 0.1 % measured after 15 days by semiquantitative PCR analysis2021Journal of natural products, 04-23, Volume: 84, Issue:4
AID1894365Anti-osteoporosis activity in FAC-induced skeletal injury Zebrafish larvae assessed as reduction in bone calcification measured for 10 day post fertilization by Alizarin red staining based assay2021Journal of natural products, 04-23, Volume: 84, Issue:4
AID1569245Inhibition of farnesyl diphosphate synthase in Balb/C mouse osteoclast assessed as reduction in [3H]MVL incorporation into prenylated proteins preincubated for 2 hrs followed by [3H]MVL addition and measured after 4 hrs by SDS-gel electrophoresis method
AID1852285Inhibition of Bacillus cereus collagenase infected in NHDF cells assessed as protection of spindle shape morphology at > 100 uM incubated for 1 to 6 hrs by coomassie brilliant blue staining based SDS-PAGE analysis2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1473738Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1569228Antiosteoporotic activity in ddY mouse model of OVX-induced osteoporosis assessed as increase in trabecular thickness in femur bone at 10 mg/kg, po administered once daily via gavage for 4 weeks by microcomputed tomographic analysis
AID1894362Induction of osteoblast differentiation in transgenic osx mCherry Zebrafish embryo assessed as increase in Sox9b mRNA expression in fin at 0.1 % measured after 15 days by semiquantitative PCR analysis2021Journal of natural products, 04-23, Volume: 84, Issue:4
AID1894367Anti-osteoporosis activity in FAC-induced skeletal injury Zebrafish larvae assessed as rescue of cartilage damage measured for 10 day post fertilization by Alizarin red staining based assay2021Journal of natural products, 04-23, Volume: 84, Issue:4
AID1569227Antiosteoporotic activity in ddY mouse model of OVX-induced osteoporosis assessed as increase in trabecular number in femur bone at 10 mg/kg, po administered once daily via gavage for 4 weeks by microcomputed tomographic analysis
AID1894364Induction of osteoblast differentiation in transgenic osx mCherry Zebrafish embryo assessed as increase in Col1a2 mRNA expression in fin at 0.1 % measured after 15 days by semiquantitative PCR analysis2021Journal of natural products, 04-23, Volume: 84, Issue:4
AID1250250Metal chelating activity in human PE/CA-PJ15 cells assessed as change in cytosolic Ca2+ concentration at 10 to 30 uM after 50 secs using Ca2+ containing medium by FURA-2 AM probe-based spectrophotofluorometric analysis2015European journal of medicinal chemistry, Sep-18, Volume: 102Synthesis of new indole-based bisphosphonates and evaluation of their chelating ability in PE/CA-PJ15 cells.
AID1569220Antiosteoporotic activity in ddY mouse model of OVX-induced osteoporosis assessed as increase in femur bone mineral density at 10 mg/kg, po administered once daily via gavage for 4 weeks by microcomputed tomographic analysis
AID1473739Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1473741Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID351141Cytotoxicity against human MADS cells at 300 nM2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
A one step/one pot synthesis of N,N-bis(phosphonomethyl)amino acids and their effects on adipogenic and osteogenic differentiation of human mesenchymal stem cells.
AID1852267Inhibition of human recombinant N-terminal his6-tagged MMP-1 expressed in HEK293 cells by microplate reader analysis2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1761538Anti-osteoporosis activity in C57BL/6 mouse BMM cells assessed as inhibition of M-CSF/RANKL-induced osteoclastogenesis by measuring reduction in multinucleated TRAP+ cells incubated for 5 days with media replenishment for every 48 hrs measured by TRAP-sta2021European journal of medicinal chemistry, Mar-05, Volume: 213Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo.
AID1852260Inhibition of Bacillus cereus collagenase unit of N-terminal His6-tagged ColQ1 expressed in Escherichia coli NiCo21(DE3) cells at 100 uM incubated for 144 seconds by FRET based assay relative to control2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1852305In vivo inhibition of Bacillus cereus AH187 ColQ1 infected in Galleria mellonella larvae assessed as increase in survival rate at 200 uM incubated for 3 days2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1569232Antiosteoporotic activity in ddY mouse model of OVX-induced osteoporosis assessed as increase in new bone volume in femur bone at 10 mg/kg, po administered once daily via gavage for 4 weeks by microcomputed tomographic analysis
AID351147Induction of osteogenesis in human MADS cells assessed as ALP activity at 0.1 to 100 nM2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
A one step/one pot synthesis of N,N-bis(phosphonomethyl)amino acids and their effects on adipogenic and osteogenic differentiation of human mesenchymal stem cells.
AID426247Antiosteoclast activity in ICR mouse osteoblast like cells co-cultured with bone marrow cells assessed as effect on 1-alpha,25(OH)2D3-induced TRAP-positive osteoclast like multinucleated cell formation at 20 uM after 6 days medium replaced every 2 days re2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.
AID1569247Cmax in healthy human at 70 mg, po in crossover study (7 day washout period) measured up to 7 hrs post dose
AID216548Activity against isopentenyl pyrophosphate (IPP) in Vgamma9 / Vdelta2 T cell2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism.
AID426249Antiosteoclast activity in ICR mouse osteoblast like cells co-cultured with bone marrow cells assessed as effect on 1-alpha,25(OH)2D3-induced TRAP-positive osteoclast like multinucleated cell formation at 200 uM after 6 days medium replaced every 2 days r2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.
AID1852299Inhibition of Bacillus cereus AH187 ColQ1 infected in MDCK-II cells assessed as transepithelial electrical resistance at 100 uM incubated for 15 hrs2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID426248Antiosteoclast activity in ICR mouse osteoblast like cells co-cultured with bone marrow cells assessed as effect on 1-alpha,25(OH)2D3-induced TRAP-positive osteoclast like multinucleated cell formation at 2 uM after 6 days medium replaced every 2 days rel2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.
AID1569243Inhibition of farnesyl diphosphate synthase in Sprague-Dawley rat liver S100 fraction using MVA as substrate preincubated for 10 min followed by MVA addition by HPLC analysis
AID1250246Metal chelating activity in human PE/CA-PJ15 cells assessed as decrease in extracellular Ca2+ concentration at 30 uM by FURA-2 AM probe-based spectrophotofluorometric analysis2015European journal of medicinal chemistry, Sep-18, Volume: 102Synthesis of new indole-based bisphosphonates and evaluation of their chelating ability in PE/CA-PJ15 cells.
AID1894380Anti-osteoporosis activity in FAC-induced skeletal injury Zebrafish assessed as increase in cumulative bone optical density in spine at 0.1 % measured for 10 day post fertilization2021Journal of natural products, 04-23, Volume: 84, Issue:4
AID1569242Inhibition of isopentenyl diphosphate isomerase in Sprague-Dawley rat liver S100 fraction preincubated for 10 min followed by MVA addition by HPLC analysis
AID1473740Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID351146Cytotoxicity against human MADS cells at 0.1 to 100 nM2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
A one step/one pot synthesis of N,N-bis(phosphonomethyl)amino acids and their effects on adipogenic and osteogenic differentiation of human mesenchymal stem cells.
AID1852252Inhibition of Clostridium histolyticum collagenase unit of ColG at 100 uM relative to control2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1229042Antiosteoclastogenic activity in Sprague-Dawley rat bone marrow-derived preosteoclasts assessed as inhibition of RANKL/M-CSF-induced osteoclast formation at 10 uM after 5 days by TRAP staining relative to vehicle-treated control2015Journal of medicinal chemistry, Jun-25, Volume: 58, Issue:12
Novel Pyrazole Derivatives Effectively Inhibit Osteoclastogenesis, a Potential Target for Treating Osteoporosis.
AID1569229Antiosteoporotic activity in ddY mouse model of OVX-induced osteoporosis assessed as reduction in trabecular separation in femur bone at 10 mg/kg, po administered once daily via gavage for 4 weeks by microcomputed tomographic analysis
AID1569244Inhibition of recombinant human farnesyl diphosphate synthase in expressed in Escherichia coli using GPP and [1-14C]IPP as substrate incubated for 15 min by scintillation counting
AID1569224Antiosteoporotic activity in ddY mouse model of OVX-induced osteoporosis assessed as increase in cross-sectional thickness in femur bone at 10 mg/kg, po administered once daily via gavage for 4 weeks by microcomputed tomographic analysis
AID1569246Cmax in healthy human at 70 mg, po in crossover study measured up to 8 hrs post dose by LC-MS/MS analysis
AID1852266Inhibition of Clostridium histolyticum peptidase unit of CoLH at 100 uM relative to contol2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1894379Anti-osteoporosis activity in FAC-induced skeletal injury Zebrafish assessed as increase in cumulative bone optical density in caudal fins at 0.1 % measured for 10 day post fertilization2021Journal of natural products, 04-23, Volume: 84, Issue:4
AID351143Effect on adipogenesis in human MADS cells assessed as GPDH activity at 300 nM2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
A one step/one pot synthesis of N,N-bis(phosphonomethyl)amino acids and their effects on adipogenic and osteogenic differentiation of human mesenchymal stem cells.
AID1894361Induction of osteoblast differentiation in transgenic osx mCherry Zebrafish embryo assessed as increase in Sox9a mRNA expression in fin at 0.1 % measured after 15 days by semiquantitative PCR analysis2021Journal of natural products, 04-23, Volume: 84, Issue:4
AID1852268Inhibition of human recombinant MMP-22022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1852287Inhibition of Bacillus cereus collagenase infected in NHDF cells assessed as reduction in LDH release at > 100 uM incubated for 30 mins by LDH assay2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID1569199Inhibition of farnesyl diphosphate synthase in Balb/C mouse osteoclast assessed as reduction in [3H]MVL incorporation into nonsaponifiable lipids preincubated for 2 hrs followed by [3H]MVL addition and measured after 4 hrs by SDS-gel electrophoresis metho
AID1569185Inhibition of M-CSF/RANKL-induced osteoclast differentiation in C57BL/6 mouse bone marrow macrophage assessed as reduction in multinucleated TRAP+ cells incubated for 6 days with fresh media replacement on day 3 and measured on day 6 by TRAP staining-base
AID1250242Lipophilicity, log P of the compound2015European journal of medicinal chemistry, Sep-18, Volume: 102Synthesis of new indole-based bisphosphonates and evaluation of their chelating ability in PE/CA-PJ15 cells.
AID351145Inhibition of osteogenesis in human MADS cells assessed as ALP activity at 300 nM2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
A one step/one pot synthesis of N,N-bis(phosphonomethyl)amino acids and their effects on adipogenic and osteogenic differentiation of human mesenchymal stem cells.
AID1250248Metal chelating activity in human PE/CA-PJ15 cells assessed as change in cytosolic Ca2+ concentration at 60 uM after 50 secs using Ca2+ free medium by FURA-2 AM probe-based spectrophotofluorometric analysis2015European journal of medicinal chemistry, Sep-18, Volume: 102Synthesis of new indole-based bisphosphonates and evaluation of their chelating ability in PE/CA-PJ15 cells.
AID216550Mean effective concentration of compound was determined in stimulating Vgamma9 / Vdelta2 T cell2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism.
AID597795Selectivity ratio of IC50 for mouse RAW264.7 cells to IC50 for mouse LLC cells2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
AID597791Cytotoxicity against mouse LLC cells after 24 hrs by resazurin assay2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
AID597794Cytotoxicity against mouse RAW264.7 cells after 72 hrs by resazurin assay2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
AID1509546Anti-osteoporosis activity in ovariectomized Sprague-Dawley rat assessed as femur bone mineral density loss at 1 mg/kg/day, po for 3 months measured post-last dose by dual energy X-ray absorptiometry (RVb = 19%)2019Journal of medicinal chemistry, 06-27, Volume: 62, Issue:12
Identifying Novel Anti-Osteoporosis Leads with a Chemotype-Assembly Approach.
AID597792Cytotoxicity against mouse LLC cells after 72 hrs by resazurin assay2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
AID597793Cytotoxicity against mouse RAW264.7 cells after 24 hrs by resazurin assay2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
AID1509551Effect on serum RANKL level in ovariectomized Sprague-Dawley rat at 1 mg/kg/day, po for 3 months measured post-last dose2019Journal of medicinal chemistry, 06-27, Volume: 62, Issue:12
Identifying Novel Anti-Osteoporosis Leads with a Chemotype-Assembly Approach.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (14.29)29.6817
2010's9 (42.86)24.3611
2020's9 (42.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]